BrainsWay H1 2026: Revenue Climbs 35% to $32.6M, Net Profit Doubles to $5.0M
BWAY sits 89% above its 52-week low of $7.135.
Summary
BrainsWay reported H1 2026 revenue of $32.6 million, up 35% year-over-year, with net profit of $5.0 million. The company also disclosed $10.1 million in new strategic investments and a 30% increase in remaining performance obligations to $80.4 million.
Key Events · Earnings and Guidance · BWAY
-
H1 Revenue Up 35% to $32.6M
Total revenues reached $32.6 million for the six months ended June 30, 2026, compared to $24.2 million in the prior-year period, driven by higher Deep TMS system sales and leases.
-
Net Profit Doubles to $5.0M
Net profit rose 60% to $5.0 million from $3.1 million, with operating profit expanding to $4.4 million from $1.2 million. Basic EPS was $0.13 versus $0.08.
-
Remaining Performance Obligations Hit $80.4M
Contracted future revenue grew 30% year-over-year to $80.4 million as of June 30, 2026, signaling sustained demand for the Deep TMS platform.
-
Strategic Investment Portfolio Expands
The company deployed $10.1 million into financial assets during H1 2026, including a $6 million convertible loan to Neurolief, $1.5 million into Hopemark, $1.0 million into BrainStim, and $0.5 million into Active Recovery.
Analysis · BWAY · Industrial Applications And Services
The first half of 2026 marked BrainsWay's strongest performance yet, with revenue up 35% to $32.6 million and net profit surging 60% to $5.0 million. The installed base expanded by 242 systems to 1,949, while remaining performance obligations—a forward indicator of contracted revenue—rose 30% to $80.4 million. Management continues to deploy cash into a portfolio of minority investments across mental health provider networks, including a $6 million convertible loan to Neurolief and new positions in Hopemark, BrainStim, and Active Recovery. Cash declined to $62.4 million from $68.0 million at year-end, reflecting both the investment activity and a lower operating cash inflow versus the prior-year period. The results confirm the commercial momentum flagged in the Q2 earnings release on August 12, but this filing adds the full balance sheet, cash flow statement, and granular investment disclosures not previously available.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BWAY was trading at $13.48 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $526.6M. The 52-week trading range was $7.14 to $17.40. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.